Osteosarcoma/ Ewing's Flashcards
Definition of osteosarcoma
Osteosarcoma incidence > Ewing’s sarcoma incidence (but Ewing’s is seen more often in younger children)
Most common primary bone malignancy of childhood / most common bone sarcoma
Occurs at the end of long bones (60-75% in knee)
M > F; 10-30yo (75% <20yo)
Clinical features of osteosarcoma
Limb is the most common site
Unexplained persistent localised bone pain
mass/swelling
restricted movement
Rapid metastasis to lung
Investigations of osteosarcoma
XR (bone destruction and formation) - esp if unexplained persistent localised bone pain
* shows destruction and variable periosteal new bone formation
* Soft tissue calcification = sunburst appearance
* Elevated periosteum = “Codman’s triangle”
Biopsy
* Malignant mesenchymal cells +/- new bone and cartilage formation
CT/PET/MRI
Chest CT scan- used to assess for lung metastases
Bone marrow sampling- excludes bone marrow involvement
Management of osteosarcoma
Make sure pt has adequate pain relief if in pain - NSAIDs, opioids may be needed
Specialised sarcoma team (London) management
Surgery (limb-sparing surgery ± amputation) + chemotherapy
Post-treatment -> OT, PT, dietician, orthotics/prosthetics, support (sarcoma UK)
Counsel the child and parents/ carers about diagnosis and treatment, reconstructive surgery or prosthetic fitting
Complications/ Prognosis of osteosarcoma
60% 5-year survival
REMEMBER: functional pain is a diagnosis of exclusion and children don’t get frozen shoulder so any patient with severe symp following a minor injury, bone tumours should be considered
Ewing’s sarcoma
Primitive Neuroendocrine Tumour (PNET) / malignant, small round blue-cell tumour
* <25y, median 15y
* Long bones of arms, legs, chest, skull and trunk
* Associated t (11:22)(EWSR1/FLI1) (q24; q12)
Signs & symptoms:
* Mass or swelling and bone pain
* Malaise, fever, paralysis (may precipitate osteomyelitis)
Investigations:
* XR (bone destruction with overlying onion-skin layers of periosteal bone formation)
* Biopsy (small round blue cells)
* CT/PET/MRI
Management:
* Specialised sarcoma team (London) management
* Surgery (limb-sparing surgery ± amputation) + chemotherapy (VIDE) + radiotherapy
* Post-treatment OT, PT, dietician, orthotics/prosthetics, support
Prognosis -> survival 5-year at 75% (20-40% for metastasis)